COMMUNIQUÉS West-GlobeNewswire

NÉOVACS ANNONCE LA NOMINATION DU Dr. VIRGINIA PASCUAL EN TANT QUE CONSEILLÈRE MÉDICALE ET SCIENTIFIQUE
27/06/2019
COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE NÉOVACS ANNONCE LA NOMINATION DU Dr. VIRGINIA PASCUAL EN TANT QUE CONSEILLÈRE MÉDICALE ET SCIENTIFIQUE Paris et Boston, le 27 juin 2019 - 07h30 CEST - [...]
Sanofi : FDA to review MenQuadfi, a meningococcal vaccine candidate
27/06/2019
FDA to review MenQuadfi TM 1 , a meningococcal vaccine candidate PARIS – June 27, 2019 - The U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for Sanofi’s MenQuadfi [...]
Sanofi : La FDA va examiner le dossier du candidat-vaccin méningococcique MenQuadfi
27/06/2019
La FDA va examiner le dossier du candidat-vaccin méningococcique MenQuadfi TM 1 PARIS – Le 27 juin 2019 - La Food and Drug Administration (FDA) des États-Unis a accepté d’examiner la demande de licence de produit [...]
Bone Therapeutics SA to raise capital through private placement of new shares and issuance of non-dilutive subordinated bonds
27/06/2019
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO [...]
Bone Therapeutics SA annonce le lancement d’un placement privé et l’émission d’obligations subordonnées non dilutives
27/06/2019
LE PRÉSENT COMMUNIQUÉ NE DOIT PAS ÊTRE PUBLIÉ, DISTRIBUÉ OU DIFFUSÉ, TOTALEMENT OU PARTIELLEMENT, DIRECTEMENT OU INDIRECTEMENT, AUX ÉTATS-UNIS, EN AUSTRALIE, AU CANADA, AU JAPON, EN AFRIQUE DU SUD, OU DANS TOUT AUTRE [...]
Atlas Nanotech of Guadalajara to begin alliance with European Nano Medical S.R.O.
27/06/2019
GUADALAJARA, Mexico, June 27, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – CSSI (Costas Inc.) DBA Atlas Nanotech has entered an accord with Nano Medical S.R.O. of the Czech Republic. The first objective of the accord aims [...]
TeraRecon Unveils iNtuition AI Data Extractor
27/06/2019
New tool enables vast customer base to automatically convert 3D post-processed studies into rich AI training data sets DURHAM, N.C., June 27, 2019 (GLOBE NEWSWIRE) -- Artificial Intelligence (AI) and advanced [...]
BridgeBio Pharma Announces Pricing of Its Initial Public Offering
27/06/2019
PALO ALTO, Calif., June 26, 2019 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (“BridgeBio”) today announced the pricing of its initial public offering of 20,500,000 shares of its common stock at a price to the public of $ [...]
Abeona Therapeutics nomme le Dr. Victor Paulus au poste de premier vice-président des affaires réglementaires
27/06/2019
NEW YORK et CLEVELAND, 27 juin 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq : ABEO), leader entièrement intégré de la thérapie génique et cellulaire, a annoncé aujourd'hui la nomination du Dr. Victor Paulus [...]
Adaptive Biotechnologies Announces Pricing of Initial Public Offering
27/06/2019
SEATTLE, June 26, 2019 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq:ADPT) (“Adaptive”), a commercial-stage biotechnology company that reads and translates the genetic code of the adaptive immune [...]
Hatch Medical Signs Manufacturing and Distribution Pact with Argon Medical Devices
26/06/2019
ATLANTA, June 26, 2019 (GLOBE NEWSWIRE) -- Medical device incubator and technology brokerage firm, Hatch Medical, L.L.C., recently announced the completion of a licensing agreement with Argon Medical Devices, Inc., a [...]
Ascent Industries Provides Update From Special General Meeting
26/06/2019
VANCOUVER, British Columbia, June 26, 2019 (GLOBE NEWSWIRE) -- Ascent Industries Corp. ( CSE: ASNT ) (“ Ascent ” or the “ Company ”) today announced that all resolutions were passed by the requisite majority at its [...]
ERYTECH Announces Enrollment of First Patient in Phase 2 Clinical Trial Evaluating Eryaspase in TNBC
26/06/2019
LYON, France and CAMBRIDGE, Mass., June 26, 2019 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drug [...]
ERYTECH annonce le recrutement de la première patiente dans son étude clinique de phase 2 évaluant eryaspase pour le traitement du cancer du sein triple négatif
26/06/2019
LYON, France, 26 juin 2019 (GLOBE NEWSWIRE) -- ERYTECH Pharma (ERYTECH) (Euronext Paris : ERYP - Nasdaq : ERYP), société biopharmaceutique de stade clinique qui développe des thérapies innovantes en encapsulant des [...]
OraSure Technologies and Others Join Forces for HIV Testing Day
26/06/2019
Free HIV tests will be available across the country to spread awareness for National HIV Testing Day on June 27. BETHLEHEM, Pa., June 26, 2019 (GLOBE NEWSWIRE) -- National HIV Testing Day will be commemorated on June 27 [...]
Forward Pharma A/S Announces Intention to Transfer its U.S. Public Listing to the Nasdaq Capital Market Stock Exchange
26/06/2019
COPENHAGEN, Denmark, June 26, 2019 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (the “Company”) today announced its intention to transfer its public listing of American Depositary Shares from the Nasdaq Global [...]
Harvard Bioscience Subsidiary Data Sciences International Launches Hardware for Expanding Research Capabilities
26/06/2019
Designed to Acquire and Synchronize Pre-clinical Signals from Disparate Sources ST. PAUL, Minn. and HOLLISTON, Mass., June 26, 2019 (GLOBE NEWSWIRE) -- Data Sciences International (DSI), a subsidiary of Harvard [...]
VIVUS and Nordmark Amend Contract Manufacturing Agreement to Supply Current and Future Demand for PANCREAZE®
26/06/2019
-Companies will also collaborate to develop additional PANCREAZE dose formulations and an advanced formulation with an extended shelf life- CAMPBELL, Calif., June 26, 2019 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS [...]
Verrica Pharmaceuticals Achieves Positive Topline Results in Phase 2 Clinical Study of VP-102 in Patients with Common Warts
26/06/2019
51% of subjects in Cohort 2 achieved complete clearance of all treatable warts VP-102 was well-tolerated with no serious adverse events reported Common warts affect approximately 22 million people in the United States [...]

Pages